Harnessing the liver’s power to regenerate
Team led by pioneering stem cell scientist is one step closer to the clinic with cell-based therapies for liver disease.
Medicine by Design symposium to highlight the power of convergence in advancing regenerative medicine
Two-day event celebrates the importance of scientific diversity in creating better science and tackling key grand questions in the field.
Using stem cells to prevent heart failure
Medicine by Design-funded research team says the new treatment approach is not far from clinical trials. This is one of the ways Medicine by Design is transforming human health.
Medicine by Design invests $1 million to advance bold new ideas in regenerative medicine
Seven funded projects poised to impact many diseases including cystic fibrosis, ALS and vision loss.
Meet our New Investigator: Omar F. Khan
Nanotechnology expert brings rich experience in academia and industry to the Institute of Biomedical Engineering.
Meet Medicine by Design’s 2020 Post-Doctoral Fellowship Award winners
Research to impact cancer, Alzheimer’s disease, autism, aneurysm and more.
Medicine by Design executive director profiled in Banting and Best Diabetes Centre story
The Banting and Best Diabetes Centre, University of Toronto (U of T), has published a profile honouring the work of Medicine by Design Executive Director Michael Sefton, who is also a University Professor at the Institute of Biomedical Engineering and the Department of Chemical Engineering & Applied Chemistry at the University of Toronto (U of T).
Medicine by Design seeds two strategic projects: An international partnership with the University of Cambridge and a new forum that will foster collaboration between clinicians, scientists and industry
$300,000 investment will accelerate new therapies and create new research tools.
Panel of Canadian regenerative medicine leaders tackle translation and commercialization challenges in panel discussion
How do trainees get started on a path toward developing a product or starting a company? What steps do researchers need to take to move their regenerative medicine discoveries from the lab toward clinical impact? These are just some of the questions an expert panel tackled on July 30 at a virtual event titled Translating Research to Impact – Leveraging Our Ecosystem.
U of T and SickKids researchers demonstrate drug stimulation of neural stem cell repair leads to promising impact on treatment of childhood brain injury in survivors of brain cancer
Cross-species study shows that Type 2 diabetes drug metformin could change the way childhood brain injury is treated
Medicine by Design’s Grand Questions Program aims to revolutionize regenerative medicine
$3 million investment to initiate answers to key questions that will transform health care